Inside Your Health: Antibody treatment

KSTP
Updated: November 15, 2020 10:44 PM
Created: November 15, 2020 10:37 PM

The world finally got some promising news about the fight against COVID-19 this past week with the announcement that Pfizer's vaccine appears to be 90% effective at stopping the coronavirus.

That huge development overshadowed another breakthrough for treating the illness: the Food and Drug Administration's emergency use authorization of bamlanivimab, a monoclonal antibody therapy.

In this week's edition of "Inside Your Health," KSTP Medical Expert Dr. Archelle Georgiou breaks down why this antibody treatment could prove to be a big step in reducing the severity of COVID-19 infections.


Copyright 2020 - KSTP-TV, LLC A Hubbard Broadcasting Company

Comment on Facebook

St. Paul police officer is being fired in connection to Saturday shooting, sources say

Brooklyn Park police seek missing teen

Maplewood barber survives transplant surgeries, COVID-19 and business closures

Charges filed against man who shot officer, 2 others in Albert Lea

Wisconsin fire chief hospitalized with COVID-19, community comes together to help the family

MDH COVID-19 briefing: State health officials discuss phases of vaccine distribution